MARKERS OF ENDOTHELIAL ACTIVATION AND COAGULATION PREDICT MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME: INSIGHTS FROM AIRACOS STUDY

被引：0
|
作者：
Avanzas, P. [1 ]
Dominguez-Rodriguez, A. [2 ]
Abreu-Gonzalez, P. [3 ]
Rodriguez, S. [4 ]
Juarez-Prera, R. [2 ]
机构：
[1] Hosp Univ Cent Asturias, Cardiol, Oviedo, Spain
[2] Hosp Univ Canarias, Cardiol, Santa Cruz De Tenerife, Spain
[3] Univ La Laguna, Dept Ciencias Med Basicas, Unidad Fisiol, Santa Cruz De Tenerife, Spain
[4] AEMET, CIAI, Santa Cruz De Tenerife, Spain
来源：
CARDIOLOGY | 2015年 / 132卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
274
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [41] EFFECTS OF VARESPLADIB METHYL ON BIOMARKERS AND MAJOR CARDIOVASCULAR EVENTS IN ACUTE CORONARY SYNDROME PATIENTS
    Rosenson, Robert S.
    Hislop, Colin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [42] Association between Peripheral Artery Disease and Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome: Findings from the Gulf COAST Registry
    Al-Zakwani, Ibrahim
    Al Siyabi, Ekram
    Alrawahi, Najib
    Al-Mulla, Arif
    Alnaeemi, Abdullah
    Shehab, Abdulla
    Zubaid, Mohammad
    MEDICAL PRINCIPLES AND PRACTICE, 2019, 28 (05) : 410 - 417
  • [43] METABOLIC SYNDROME AND THE RISK OF ADVERSE CARDIOVASCULAR EVENTS AFTER AN ACUTE CORONARY SYNDROME: INSIGHTS FROM SOLID-TIMI 52 TRIAL
    Cavallari, Ilaria
    Cannon, Christopher
    Braunwald, Eugene
    Goodrich, Erica
    Im, Kyungah
    Lukas, Mary Ann
    O'Donoghue, Michelle
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 448 - 448
  • [44] Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events
    K N Aronis
    M Moreno
    S A Polyzos
    J M Moreno-Navarrete
    W Ricart
    E Delgado
    J de la Hera
    A Sahin-Efe
    J P Chamberland
    R Berman
    A Spiro III
    P Vokonas
    J M Fernández-Real
    C S Mantzoros
    International Journal of Obesity, 2015, 39 : 156 - 161
  • [45] Hyperuricemia as a Risk Factors of Major Adverse Cardiac Events in Patients with Acute Coronary Syndrome: a Retrospective Cohort Study
    Karim, Birry
    Nasution, Sally A.
    Wijaya, Ika P.
    Harimurti, Kuntjoro
    ACTA MEDICA INDONESIANA, 2015, 47 (04) : 320 - 325
  • [46] Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events
    Aronis, K. N.
    Moreno, M.
    Polyzos, S. A.
    Moreno-Navarrete, J. M.
    Ricart, W.
    Delgado, E.
    de la Hera, J.
    Sahin-Efe, A.
    Chamberland, J. P.
    Berman, R.
    Spiro, A., III
    Vokonas, P.
    Fernandez-Real, J. M.
    Mantzoros, C. S.
    INTERNATIONAL JOURNAL OF OBESITY, 2015, 39 (01) : 156 - 161
  • [47] Thrombospondin-1 plasma levels associated with in-hospital major adverse cardiovascular events in patients with acute coronary syndrome
    Ma, Zheng
    Wang, Meiping
    Xu, Xiaorong
    Zhang, Yeping
    Zhong, Jiuchang
    Chen, Mulei
    Su, Pixiong
    Zhao, Lei
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 375 : 98 - 103
  • [48] Prognostic role of the left ventricular global function index in predicting major adverse cardiovascular events in acute coronary syndrome patients
    Doganay, Birsen
    Celebi, Ozlem Ozcan
    BIOMARKERS IN MEDICINE, 2023, 17 (01) : 5 - 16
  • [49] Homocysteine as a potential predictive factor for high major adverse cardiovascular events risk in female patients with premature acute coronary syndrome
    Wei, Mei
    Wang, Le
    Liu, Yong-Sheng
    Zheng, Ming-Qi
    Ma, Fang-Fang
    Qi, Yan-Chao
    Liu, Gang
    MEDICINE, 2019, 98 (47)
  • [50] Glycaemic variability and risk of adverse cardiovascular events in acute coronary syndrome
    Zhang, Lei
    Li, Feng
    Liu, Huan-Huan
    Zhang, Zhi-Yuan
    Yang, Fan
    Qian, Ling-Ling
    Wang, Ru-Xing
    DIABETES & VASCULAR DISEASE RESEARCH, 2022, 19 (06):
12345